Maladie de Huntington : signalisation intracellulaire et mort neuronale
J. Soc. Biol., 199 3 (2005) 247-251
Publié en ligne : 2008-01-01
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Chrysin ameliorates 3 nitropropinoic acid induced neurotoxicity targeting behavioural, biochemical and histological alterations
Madiha Haider, Mohd. Salman, Pooja Kaushik, et al.International Journal of Neuroscience 132 (5) 450 (2022)
https://doi.org/10.1080/00207454.2020.1821677
Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases
Yu-Qing Ni, Hui Xu and You-Shuo LiuFrontiers in Molecular Neuroscience 15 (2022)
https://doi.org/10.3389/fnmol.2022.844193
Dexamethasone Protects Against Ischaemic Brain Injury via Inhibiting the pAkt Signalling Pathway Through Increasing Hap1
Ning Xin, Jun Lu, Yanlong Zhou and Yanbo ChengNeurotoxicity Research 39 (2) 191 (2021)
https://doi.org/10.1007/s12640-020-00255-4
Synapse Development and Maturation
Freddy Jeanneteau, Margarita Arango-Lievano and Moses V. ChaoSynapse Development and Maturation 167 (2020)
https://doi.org/10.1016/B978-0-12-823672-7.00007-7
Huntington disease: Advances in the understanding of its mechanisms
Emilia M. Gatto, Natalia González Rojas, Gabriel Persi, et al.Clinical Parkinsonism & Related Disorders 3 100056 (2020)
https://doi.org/10.1016/j.prdoa.2020.100056
Advanced Targeted Nanomedicine
Uche Chude-Okonkwo, Reza Malekian and B. T. MaharajNanomedicine and Nanotoxicology, Advanced Targeted Nanomedicine 19 (2019)
https://doi.org/10.1007/978-3-030-11003-1_2
The S1P Axis: New Exciting Route for Treating Huntington’s Disease
Alba Di Pardo and Vittorio MaglioneTrends in Pharmacological Sciences 39 (5) 468 (2018)
https://doi.org/10.1016/j.tips.2018.02.009
A central role for calcineurin in protein misfolding neurodegenerative diseases
Syed Zahid Ali Shah, Tariq Hussain, Deming Zhao and Lifeng YangCellular and Molecular Life Sciences 74 (6) 1061 (2017)
https://doi.org/10.1007/s00018-016-2379-7
LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington’s Disease
Vanita Chopra, Luisa Quinti, Prarthana Khanna, et al.Journal of Huntington's Disease 5 (4) 347 (2016)
https://doi.org/10.3233/JHD-160226
Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress
Abhisek Mukherjee and Claudio SotoCurrent Opinion in Cell Biology 23 (2) 223 (2011)
https://doi.org/10.1016/j.ceb.2010.12.006
Huntingtin-associated Protein-1 Interacts with Pro-brain-derived Neurotrophic Factor and Mediates Its Transport and Release
Linda Lin-yan Wu, Yongjun Fan, Shihua Li, Xiao-Jiang Li and Xin-Fu ZhouJournal of Biological Chemistry 285 (8) 5614 (2010)
https://doi.org/10.1074/jbc.M109.073197
Intracranial self-stimulation to the lateral hypothalamus, a memory improving treatment, results in hippocampal changes in gene expression
G. Huguet, L. Aldavert-Vera, E. Kádár, et al.Neuroscience 162 (2) 359 (2009)
https://doi.org/10.1016/j.neuroscience.2009.04.074
Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes
Szu-Yi Chou, Ju-Yun Weng, Hsing-Lin Lai, et al.The Journal of Neuroscience 28 (13) 3277 (2008)
https://doi.org/10.1523/JNEUROSCI.0116-08.2008
Huntington's disease: seeing the pathogenic process through a genetic lens
James F. Gusella and Marcy E. MacDonaldTrends in Biochemical Sciences 31 (9) 533 (2006)
https://doi.org/10.1016/j.tibs.2006.06.009